$LumiraDx (LMDXF.US)$ This is for informational purposes onl...

$LumiraDx (LMDXF.US)$ This is for informational purposes only. For financial advice or investment decisions, consult a qualified professional.

Given the timeline you provided:

* **December 29, 2023:** Roche signed the deal to acquire LumiraDx's Point of Care technology business.
* **February 1, 2024:** The liquidation process for LumiraDx began.

It's difficult to give an exact timeframe for when shareholders will know the final details. Liquidation processes can vary significantly in length and complexity. However, considering the time that has passed since the start of the liquidation process, it's possible that shareholders could receive updates or information in the **coming months**.

**Here are some factors that could influence the timeline:**

* **Complexity of Liquidation:** The complexity of LumiraDx's assets, liabilities, and legal entanglements will influence how quickly the liquidation process can be completed.
* **Negotiations and Agreements:** Reaching agreements with creditors, resolving legal disputes, and finalizing the distribution of assets can take time.
* **Regulatory Approvals:** Depending on the specific circumstances, regulatory approvals may be required for certain aspects of the liquidation process.

**It's crucial for LumiraDx shareholders to:**

* **Stay Informed:** Monitor for official announcements and updates from the administrators.
* **Consult with Professionals:** Seek guidance from financial or legal professionals who can provide personalized advice based on their individual circumstances.

**Disclaimer:** This information is for general knowledge and informational purposes only and does not constitute financial advice.

**Please note:** This is an estimate and the actual timeline could be shorter or longer.

**I recommend staying vigilant and seeking professional guidance for the most accurate and up-to-date information.**